Aadel Chaudhuri, MD PhD
@aadel_chaudhuri
Vice Chair of Translational Research & Associate Professor @MayoRadOnc | Co-Director of Cancer Precision Medicine & Emerging Leader @MayoCancerCare @MayoClinic
ID:911249380329402368
22-09-2017 15:22:37
5,9K Tweets
2,7K Followers
810 Following
Awesome news: “This year, the PD Soros Fellowships Fellowship was awarded to 30 graduate students, including Abigail Jiang, who graduated from Caltech in 2023 with a double major in materials science and history, and is now studying applied physics at Harvard University.” pdsoros.org/meet-the-fello…
Very excited to have Dennis Lo deliver the opening address at the NIH #LiquidBiopsy conference that I’m co-chairing with All-⭐️s Adam Sowalsky Bruna Pellini, MD Aaron Newman Lab.
Should be one heck of a conference! See you there/then National Cancer Institute in Bethesda!!
I’m grateful to be on the programming committee & chair the ECI Council for Radiation Research Society. All I can say is: This is turning out to be a great meeting. So submit your abstracts by Wed!!
Mayo Clinic Radiation Oncology
Congrats, Jeff (and a huge win for your team Aadel Chaudhuri, MD PhD !)! So excited to keep working with you in your new role!
.Mayo Clinic Comprehensive Cancer Center director @cherylwillmanmd is part of NCI Disparities’s newly established team of Cancer Equity Leaders. This diverse group of cancer leaders will reimagine and transform the future of cancer #HealthEquity . Learn more: bit.ly/49zzAMv
Been following the Coldwater Creek story in St. Louis for a while & wondered how we could use next-gen liquid biopsy ctDNA testing to detect cancer cases in at-risk communities.
So Nick Semenkovich, MD PhD, Gautum Agarwal & I wrote a paper on this overall topic coming out in JAMA Oncology. Stay tuned!
The new Kellen Research Building Mayo Clinic is pretty remarkable. Ultra-modern & highly functional. Fully dedicated to biomedical research.
Grateful to be there!!
The first-ever NIH-wide conference on liquid biopsies will feature lunchtime interactive sessions on clinical implementation. Foundation Medicine's Dave Fabrizio and AstraZeneca's Diana Vega will discuss molecular residual disease! Registration is required: ncifrederick.cancer.gov/events/confere…
I love this team!!
Fun to hangout with them at #AACR24 & see how incredibly far they’ve come. #GreatData
Onward my friends!
José P. Zevallos, MD, MPH, FACS